Claudia Riedl
Director/Board Member at VIVORYON THERAPEUTICS N.V.
Network origin in Claudia Riedl first degree
Entity | Entity type | Industry | |
---|---|---|---|
Public Company | Biotechnology | 10 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Claudia Riedl via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
DEUTSCHE BANK AG | Investment Banks/Brokers | Corporate Officer/Principal | |
MERCK KGAA | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
HBM Partners AG
HBM Partners AG Investment ManagersFinance HBM Partners AG (HBM-P) was established in 2001 as an independent provider of investment advisory services with headquarters in Zug, Switzerland. HBM-P's field of expertise comprises global human medicine, biotechnology, medical technology and related sectors. The firm primarily advises HBM BioVentures AG and HBM BioCapital via their Cayman Islands-based, wholly-owned subsidiary, HBM Partners (Cayman) Ltd., which acts as the investment manager for the HBM funds. They rely on the services of an external consultant to analyze investment opportunities in the US. | Investment Managers | Founder | |
4SC AG | Biotechnology | Chairman Chief Executive Officer | |
ProBioGen AG
ProBioGen AG Miscellaneous Commercial ServicesCommercial Services ProBioGen AG operates as a contract development and manufacturing organization. It specializes in cell line engineering, process development, and GMP manufacturing of biopharmaceuticals. The firm offers services such as cell line development, process development, manufacturing programs, physio-chemical analyses, and cell-based assays. The company was founded by Uwe Marx on June 13, 1994 and is headquartered in Berlin, Germany. | Miscellaneous Commercial Services | Director/Board Member | |
NOVARTIS AG | Pharmaceuticals: Major | Public Communications Contact | |
University of Pennsylvania | College/University | Graduate Degree | |
MORPHOSYS AG | Biotechnology | Human Resources Officer | |
LSP Management Group BV
LSP Management Group BV Investment ManagersFinance LSP Management Group BV (LSP) is an independent European venture capital firm which was founded by Martijn Kleijwegt, Frits van der Have and Tom Schwarz in 1998. Headquartered in Amsterdam, the firm provides financing to early- to mid-stage life science companies. | Investment Managers | Corporate Officer/Principal | |
Massachusetts Institute of Technology | College/University | Undergraduate Degree | |
GLOBAL PVQ SE | Semiconductors | Director/Board Member | |
Universität zu Köln | College/University | Doctorate Degree | |
HEIDELBERG PHARMA AG | Pharmaceuticals: Major | Human Resources Officer | |
IDEA AG
IDEA AG Pharmaceuticals: MajorHealth Technology IDEA AG develops pain therapeutics and biopharmaceutical drugs. The firm develops and commercializes non-invasive therapeutic drugs and the targeted pain therapeutics for arthritic and osteoporosis-related inflammation, chronic pain and diseases. Its technology platform is based on proprietary carriers applied on skin and engineered to diminish side effects and increase drug potency. The company founded by Gregor Cevc in 1993 and is headquartered in Munich, Germany. | Pharmaceuticals: Major | Director/Board Member | |
The University of Sheffield | College/University | Doctorate Degree | |
University of Warwick | College/University | Masters Business Admin | |
Freie Universität Berlin | College/University | Doctorate Degree | |
IBG Beteiligungsgesellschaft Sachsen-Anhalt mbH
IBG Beteiligungsgesellschaft Sachsen-Anhalt mbH Investment ManagersFinance Beteiligungsgesellschaft Sachsen-Anhalt mbH is a private equity/ venture capital firm founded in 1996. The firm is headquartered in Magedeburg. | Investment Managers | Chief Executive Officer | |
SPEXIS AG | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Scienion AG
Scienion AG BiotechnologyHealth Technology Scienion AG develops and provides DNA biochips and protein microarrays. It provides its customers in the pharmaceutical, biotech, diagnostic and reagent supply markets, as well as in academic research institutions with products, and services to facilitate confidence and efficiency in aspects of its applications. The company was founded by Holger Eickhoff in 2000 and is headquartered in Dortmund, Germany. | Biotechnology | Chairman | |
Ludwig-Maximilians-Universität München | College/University | Graduate Degree Doctorate Degree Undergraduate Degree | |
Merck Serono SA
Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
Creathor Venture Management GmbH
Creathor Venture Management GmbH Investment ManagersFinance Creathor Venture Management GmbH is an independent private equity firm specialized in technology venture capital investing. Creathor was foundedi n 2003 and is headquartered in Bad Homburg near Frankfurt in central Germany. The management invests their own capital, and manages venture capital funds on behalf of institutions. | Investment Managers | Private Equity Investor | |
Market Logic Software AG
Market Logic Software AG Packaged SoftwareTechnology Services Market Logic Software AG designs and develops enterprise business software for product management. Its software helps to manage research, search information, build knowledge, guide innovation, plan marketing and drive sales. The firm provides marketing information systems to the marketing and research teams. Its clients include global brands from FMCG and CPG, healthcare, retail, high-tech, finance and communications sectors and research agencies. The company was founded by Kay Iversen in 2006 and is headquartered in Berlin, Germany. | Packaged Software | Director/Board Member | |
Acktar Ltd.
Acktar Ltd. Chemicals: Major DiversifiedProcess Industries Acktar Ltd. engages in the development, industrialization and production of black light absorbing coating. Its products include light absorbing foils, die-cuts solutions, optical components, black optical coatings, high specific surface area coatings, vacuum coater and high capacitance anode and cathode foils. The firm also offers coating services that include black optical coating and light absorbing foil. It serves the space, defense, semiconductor, solar energy and commercial industries. The company was founded in 1994 by Zvi Finkelstein and Dina Katsir and is headquartered in Kiryat-Gat, Israel. | Chemicals: Major Diversified | Director/Board Member | |
CODIXX AG
CODIXX AG Electronic Production EquipmentElectronic Technology CODIXX AG specializes in the production, development, and distribution of glass polarizers. It encompasses visible and infrared standard, ultraviolet, and high-transmittance polarizers. The company was founded on September 1, 1998 and is headquartered in Barleben, Germany. | Electronic Production Equipment | Director/Board Member | |
Karlsruher Institut für Technologie | College/University | Undergraduate Degree | |
Julius-Maximilians-Universität Würzburg | College/University | Doctorate Degree | |
TRUST Versicherungsmakler AG | Chairman | ||
Franklin Templeton Investment Management Ltd. (Germany)
Franklin Templeton Investment Management Ltd. (Germany) Investment ManagersFinance Franklin Templeton Investment Management Ltd. (Germany) (FTIML-Germany) is the German investment management division of Great Britain-based Franklin Templeton Investment Management Ltd., ultimately owned by Franklin Resources, Inc. (NYSE: BEN) in the US. Headquartered in Frankfurt, the firm was founded in 1992 and manages the Franklin Templeton Investments fund range for individuals, pension funds, trusts, local authorities, corporations, government bodies, fund of funds and multi-managers. | Investment Managers | Analyst-Equity | |
Joseph H Lauder Institute of Management & International | College/University | Graduate Degree | |
ImCyse SA
ImCyse SA BiotechnologyHealth Technology ImCyse SA engages in the development of curative therapies in the field of immune and allergic pathologies. It offers a technological platform that helps develop medicinal products with potential benefits in all clinical circumstances where HLA class II restricted specific immunity can be causative of or contribute to damages to humans or animals. The firm's products are used in organ-specific autoimmunity, allergy, alloimmunity, cancer and infectious diseases. The company was founded in August 2010 by Jean-Marie R. Saint-Remy and is headquartered in Liege, Belgium. | Biotechnology | Director/Board Member | |
Crelux GmbH
Crelux GmbH BiotechnologyHealth Technology Crelux GmbH provides structure based drug discovery solutions. The firm provides customized services to support hit-finding, conformational analysis and lead optimization, including protein production, biophysical assays, fragment screening, and X-ray crystallography. It works for pharma, biotech and research organizations. The company was founded by Ismail Moarefi, Martin Ried and Michael Schaeffer and is headquartered in Martinsried, Germany. | Biotechnology | Chief Executive Officer | |
Elector GmbH
Elector GmbH Financial ConglomeratesFinance Elector GmbH engages in the acquisition, holding, and management of participating interests in firms. The company was founded on November 20, 2012 and is headquartered in Berlin, Germany. | Financial Conglomerates | Chief Executive Officer | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
Harvard Business School | College/University | Undergraduate Degree | |
OMEICOS Therapeutics GmbH
OMEICOS Therapeutics GmbH BiotechnologyHealth Technology OMEICOS Therapeutics GmbH develops small molecules using endogenous protective mechanism for the treatment and prevention of atrial fibrillation. It operates as a biopharmaceutical company developing molecule therapeutics for the prevention and treatment of cardiovascular diseases including atrial fibrillation. The company was founded by Wolf-Hagen Schunck, John R. Falck, Dominik Müller, Robert Fischer and Karen Uhlmann in 2013 and is headquartered in Berlin, Germany. | Biotechnology | Chief Executive Officer | |
Ventaleon GmbH
Ventaleon GmbH Pharmaceuticals: OtherHealth Technology Ventaleon GmbH is a biotechnology company, which engages in the development of inhaled treatments against viral infections. Its products include LASAG (D,L-lysine acetylsalicylate • glycine), a lysin-salt formulation of well known acetyl salicylic acid. The company was founded by Gerhard Scheuch in 2012 and is headquartered in Gauting, Germany. | Pharmaceuticals: Other | Director/Board Member Chief Executive Officer | |
Technocommerz GmbH | Director/Board Member | ||
Immunic AG
Immunic AG Pharmaceuticals: MajorHealth Technology Immunic AG develops pharmaceuticals in the immunology space. The firm offers immune modulators to block TH17-and TH1-mediated immune and autoimmune responses. The company was founded by Andreas Muhler and Manfred Groppel in April 2016 and is headquartered in Martinsried, Germany. | Pharmaceuticals: Major | Chairman | |
InterMune International AG | Corporate Officer/Principal | ||
Atriva Therapeutics GmbH
Atriva Therapeutics GmbH BiotechnologyHealth Technology Atriva Therapeutics GmbH is a biopharmaceutical company that develops host-targeting antiviral therapies. It focuses on the development of new antiviral therapies against different respiratory viral infections. The company was founded by Rainer Lichtenberger and Henrik Luer Lueßen in April 2015 and is headquartered in Tuebingen, Germany. | Biotechnology | Director/Board Member | |
IMMUNIC, INC. | Pharmaceuticals: Major | Director/Board Member | |
Curexsys GmbH
Curexsys GmbH Miscellaneous Commercial ServicesCommercial Services Curexsys GmbH is a German company founded by molecular biologist Jens Gruber and biochemist Dr. Herbert Stadler. The company is based in Goettingen, Germany. The company aims to become a leading supplier for clinical grade exosomes in regenerative medicine and anti-aging therapies. Exosomes are extracellular, nanoscale vesicles that transfer information to neighboring cells and distant tissues. Curexsys is currently pursuing the development of several programs in three indications, focusing on the generation of clearly defined, characterized, and purified extracellular vesicles/exosomes from their proprietary iMSC lines derived from Evotec's iPSC platform. | Miscellaneous Commercial Services | Chief Executive Officer | |
Vectura GmbH
Vectura GmbH Medical SpecialtiesHealth Technology Vectura GmbH manufactures and develops pharmaceutical therapies for airways diseases. It offers dry powder formulation technology, device technology, and development capabilities. The company was founded by Gerhard Scheuch in 1997 and is headquartered in Gemünden, Germany. | Medical Specialties | Director/Board Member Corporate Officer/Principal | |
MedNet GmbH
MedNet GmbH Medical DistributorsDistribution Services MedNet GmbH provides standard and customized components for medical devices and other industries from a single source. The private company is based in Muenster, Germany. The CEOs are David Thaler, Inge Bröskamp. The German company was founded in 1990. | Medical Distributors | Corporate Officer/Principal |
Statistics
International
Germany | 34 |
United States | 8 |
Switzerland | 6 |
United Kingdom | 3 |
Netherlands | 2 |
Sectoral
Health Technology | 18 |
Consumer Services | 12 |
Finance | 11 |
Commercial Services | 5 |
Electronic Technology | 3 |
Operational
Director/Board Member | 57 |
Chairman | 13 |
Corporate Officer/Principal | 12 |
Chief Executive Officer | 12 |
Undergraduate Degree | 7 |
Most connected contacts
- Stock Market
- Insiders
- Claudia Riedl
- Company connections